General Information of Drug (ID: DMHJIN0)

Drug Name
6-Chloro-4-morpholin-4-yl-chromen-2-one
Synonyms CHEMBL179591; 6-chloro-4-morpholin-4-yl-chromen-2-one
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 265.69
Logarithm of the Partition Coefficient (xlogp) 2
Rotatable Bond Count (rotbonds) 1
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C13H12ClNO3
IUPAC Name
6-chloro-4-morpholin-4-ylchromen-2-one
Canonical SMILES
C1COCCN1C2=CC(=O)OC3=C2C=C(C=C3)Cl
InChI
InChI=1S/C13H12ClNO3/c14-9-1-2-12-10(7-9)11(8-13(16)18-12)15-3-5-17-6-4-15/h1-2,7-8H,3-6H2
InChIKey
IKOYKMNERRYCAN-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
11459783
TTD ID
D04SCD

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
DNA-dependent protein kinase catalytic (PRKDC) TTK3PY9 PRKDC_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Selective benzopyranone and pyrimido[2,1-a]isoquinolin-4-one inhibitors of DNA-dependent protein kinase: synthesis, structure-activity studies, and... J Med Chem. 2005 Jan 27;48(2):569-85.